BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27904502)

  • 1. Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury.
    Li XG; Lin XJ; Du JH; Xu SZ; Lou XF; Chen Z
    Neural Regen Res; 2016 Oct; 11(10):1678-1684. PubMed ID: 27904502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a single dose of methylprednisolone versus three doses of rosiglitazone on nerve growth factor levels after spinal cord injury.
    Meng B; Zhang Q; Huang C; Zhang HT; Tang T; Yang HL
    J Int Med Res; 2011; 39(3):805-14. PubMed ID: 21819712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate combined with methylprednisolone for the recovery of motor function and differential gene expression in rats with spinal cord injury.
    Liu JT; Zhang S; Gu B; Li HN; Wang SY; Zhang SY
    Neural Regen Res; 2017 Sep; 12(9):1507-1518. PubMed ID: 29089998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
    Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
    Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone promotes recovery of neurological function after spinal cord injury: association with Wnt/β-catenin signaling pathway activation.
    Lu GB; Niu FW; Zhang YC; Du L; Liang ZY; Gao Y; Yan TZ; Nie ZK; Gao K
    Neural Regen Res; 2016 Nov; 11(11):1816-1823. PubMed ID: 28123427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Rosiglitazone and Forskolin Have Neuroprotective Effects in SD Rats after Spinal Cord Injury.
    Meng QQ; Lei W; Chen H; Feng ZC; Hu LQ; Zhang XL; Li S
    PPAR Res; 2018; 2018():3897478. PubMed ID: 30034460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ agonist rosiglitazone reduces secondary damage in experimental spinal cord injury.
    Li X; Du J; Xu S; Lin X; Ling Z
    J Int Med Res; 2013 Feb; 41(1):153-61. PubMed ID: 23569141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy of methylprednisolone and brain-derived neurotrophic factor promotes axonal regeneration and functional recovery after spinal cord injury in rats.
    Li L; Xu Q; Wu Y; Hu W; Gu P; Fu Z
    Chin Med J (Engl); 2003 Mar; 116(3):414-8. PubMed ID: 12781049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARγ agonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats.
    Zhang Q; Hu W; Meng B; Tang T
    Neurol Res; 2010 Oct; 32(8):852-9. PubMed ID: 20350367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study.
    Bracken MB; Shepard MJ; Holford TR; Leo-Summers L; Aldrich EF; Fazl M; Fehlings M; Herr DL; Hitchon PW; Marshall LF; Nockels RP; Pascale V; Perot PL; Piepmeier J; Sonntag VK; Wagner F; Wilberger JE; Winn HR; Young W
    JAMA; 1997 May; 277(20):1597-604. PubMed ID: 9168289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of basic fibroblast growth factor and methylprednisolone on neurological function after experimental spinal cord injury.
    Baffour R; Achanta K; Kaufman J; Berman J; Garb JL; Rhee S; Friedmann P
    J Neurosurg; 1995 Jul; 83(1):105-10. PubMed ID: 7540200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats.
    Constantini S; Young W
    J Neurosurg; 1994 Jan; 80(1):97-111. PubMed ID: 8271028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rosiglitazone enhances the proliferation of neural progenitor cells and inhibits inflammation response after spinal cord injury.
    Meng QQ; Liang XJ; Wang P; Wang XP; Yang JW; Wu YF; Shen HY
    Neurosci Lett; 2011 Oct; 503(3):191-5. PubMed ID: 21889575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for acute spinal cord injury.
    Bracken MB
    Cochrane Database Syst Rev; 2000; (2):CD001046. PubMed ID: 10796741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological and functional status 1 year after acute spinal cord injury: estimates of functional recovery in National Acute Spinal Cord Injury Study II from results modeled in National Acute Spinal Cord Injury Study III.
    Bracken MB; Holford TR
    J Neurosurg; 2002 Apr; 96(3 Suppl):259-66. PubMed ID: 11990832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats.
    Hara M; Takayasu M; Watanabe K; Noda A; Takagi T; Suzuki Y; Yoshida J
    J Neurosurg; 2000 Jul; 93(1 Suppl):94-101. PubMed ID: 10879764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, and NMDA receptor antagonist (MK-801) on experimental embolic stroke in rats.
    Allahtavakoli M; Shabanzadeh A; Roohbakhsh A; Pourshanazari A
    Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):309-14. PubMed ID: 17910613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect evaluation of methylprednisolone plus mitochondrial division inhibitor-1 on spinal cord injury rats.
    Chen XG; Chen LH; Xu RX; Zhang HT
    Childs Nerv Syst; 2018 Aug; 34(8):1479-1487. PubMed ID: 29682689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-
    Meng QQ; Feng ZC; Zhang XL; Hu LQ; Wang M; Zhang HF; Li SM
    Mediators Inflamm; 2019; 2019():6386729. PubMed ID: 31015796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic time window for methylprednisolone in spinal cord injured rat.
    Yoon DH; Kim YS; Young W
    Yonsei Med J; 1999 Aug; 40(4):313-20. PubMed ID: 10487132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.